SLC41A3 and hepatocellular carcinoma: Conversely, high SLC41A3 expression is closely correlated with poor prognosis in hepatocellular carcinoma patients, leading to a significantly shorter survival period in patients with elevated SLC41A3 expression than in those with normal SLC41A3 expression [29].